Skip to main content

Advertisement

Log in

Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

Familial adenomatous polyposis (FAP) is characterised by colonic and duodenal adenomatous polyps that carry a risk of malignant transformation. Malignant degeneration of duodenal adenomas is difficult to detect. We speculated that 2-(18F)-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) might be able to detect early duodenal cancer in FAP. Accordingly, we investigated the role of FDG-PET in the management of FAP patients.

Methods

FDG-PET was performed in 24 FAP patients. Eight had advanced duodenal adenomas (Spigelman IV), including two patients with duodenal cancer. Scans were defined as positive on the basis of focal FDG accumulation.

Results

Pathological FDG accumulation was absent in 19 of 24 patients. All six patients with Spigelman IV duodenal adenomas (without cancer) were negative; two of these underwent a duodenectomy and pathological examination did not reveal duodenal cancer. In five patients, FDG-PET revealed significant uptake, in the duodenum (2), lower abdomen (1), lung (1) and multiple sites in the abdomen (1). These hot spots correlated with duodenal cancer (2), abdominal metastasis (1) and sclerosing haemangioma of the lung (1). We failed to make a histopathological diagnosis in the single patient with multiple intra-abdominal sites of FDG uptake. None of the patients from the FDG-PET-negative group developed cancer during follow-up (mean 2.8 years).

Conclusion

FDG-PET detected all the cancers present, and none of the patients with negative FDG-PET developed cancer. This suggests that positive FDG-PET in FAP patients should lead to further examinations to rule out cancer. In patients with negative FDG-PET a more conservative approach seems justified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Allen BA, Terdiman JP. Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer. Best Pract Res Clin Gastroenterol 2003;17(2):237–58

    Article  PubMed  Google Scholar 

  2. Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102(6):1980–2

    PubMed  Google Scholar 

  3. Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 2001;16(2):63–75

    Article  PubMed  Google Scholar 

  4. Bulow S, Bjork J, Christensen IJ, Fausa O, Jarvinen H, Moesgaard F, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53(3):381–6

    Article  PubMed  Google Scholar 

  5. Church JM, McGannon E, Hull-Boiner S, Sivak MV, van Stolk R, Jagelman DG, et al. Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992;35(12):1170–3

    PubMed  Google Scholar 

  6. Stolte M, Pscherer C. Adenoma–carcinoma sequence in the papilla of Vater. Scand J Gastroenterol 1996;31(4):376–82

    PubMed  Google Scholar 

  7. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2(8666):783–5

    Article  PubMed  Google Scholar 

  8. Groves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50(5):636–41

    Article  PubMed  Google Scholar 

  9. Cahen DL, Fockens P, de Wit LT, Offerhaus GJ, Obertop H, Gouma DJ. Local resection or pancreaticoduodenectomy for villous adenoma of the ampulla of Vater diagnosed before operation. Br J Surg 1997;84(7):948–51

    PubMed  Google Scholar 

  10. Shoup M, Hodul P, Aranha GV, Choe D, Olson M, Leya J, et al. Defining a role for endoscopic ultrasound in staging periampullary tumors. Am J Surg 2000;179(6):453–6

    Article  PubMed  Google Scholar 

  11. Schwarz M, Pauls S, Sokiranski R, Brambs HJ, Glasbrenner B, Adler G, et al. Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective? Am J Surg 2001;182(3):243–9

    Article  PubMed  Google Scholar 

  12. Abulafi AM, Allardice JT, Williams NS, van Someren N, Swain CP, Ainley C. Photodynamic therapy for malignant tumours of the ampulla of Vater. Gut 1995;36(6):853–6

    PubMed  Google Scholar 

  13. Gallagher MC, Shankar A, Groves CJ, Russell RC, Phillips RK. Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis. Br J Surg 2004;91(9):1157–64

    Article  PubMed  Google Scholar 

  14. Kalady MF, Clary BM, Tyler DS, Pappas TN. Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg 2002;6(1):82–7

    Article  PubMed  Google Scholar 

  15. Sarmiento JM, Thompson GB, Nagorney DM, Donohue JH, Farnell MB. Pancreas-sparing duodenectomy for duodenal polyposis. Arch Surg 2002;137(5):557–62

    Article  PubMed  Google Scholar 

  16. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer—a meta-analysis. Ann Intern Med 2003;139(11):879–92

    PubMed  Google Scholar 

  17. Bleeker-Rovers CP, Bredie SJ, van der Meer JW, Corstens FH, Oyen WJ. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 2003;61(10):323–9

    PubMed  Google Scholar 

  18. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47(2):251–5

    Article  PubMed  Google Scholar 

  19. Hosaka N, Sasaki T, Adachi K, Sato T, Tanaka T, Miura Y, et al. Pulmonary sclerosing hemangioma associated with familial adenomatous polyposis. Hum Pathol 2004;35(6):764–8

    Article  PubMed  Google Scholar 

  20. Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S. Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 1996;56(9):2213–7

    PubMed  Google Scholar 

  21. Henderson BR. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2000;2(9):653–60

    Article  PubMed  Google Scholar 

  22. Hara M, Iida A, Tohyama J, Miura N, Shiraki N, Itoh M, et al. FDG-PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med 2001;19(4):215–8

    PubMed  Google Scholar 

  23. Tanaka I, Inoue M, Matsui Y, Oritsu S, Akiyama O, Takemura T, et al. A case of pneumocytoma (so-called sclerosing hemangioma) with lymph node metastasis. Jpn J Clin Oncol 1986;16(1):77–86

    PubMed  Google Scholar 

  24. Noguchi M, Kodama T, Morinaga S, Shimosato Y, Saito T, Tsuboi E. Multiple sclerosing hemangiomas of the lung. Am J Surg Pathol 1986;10(6):429–35

    PubMed  Google Scholar 

  25. Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med 2001;28(12):1766–9

    Article  PubMed  Google Scholar 

  26. Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W, Ide M, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med 2001;42(7):989–92

    PubMed  Google Scholar 

  27. van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP. 2-(18F)-fluoro-2-deoxy-d-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 2005;23(16):3713–7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fokko M. Nagengast.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Kouwen, M.C.A., Drenth, J.P.H., van Krieken, J.H.J.M. et al. Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management. Eur J Nucl Med Mol Imaging 33, 270–274 (2006). https://doi.org/10.1007/s00259-005-1955-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-005-1955-0

Keywords

Navigation